Panbela Therapeutics Total Liabilities

Panbela Therapeutics (PBLA) currently reports a total liabilities of $23M as of September 2024. That compares with $13M in the prior-year period — up 78.0% year over year. Use the charts on this page to explore Panbela Therapeutics's total liabilities history and peer comparisons.

Panbela Therapeutics's total liabilities increased from $13M to $23M — a 78.0% year-over-year increase (period ending September 2024). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Panbela Therapeutics reported $23M in total liabilities as of September 2024. That compares with $13M in the prior-year period — up 78.0% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current total liabilities of $23M, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Panbela Therapeutics, and consider following PBLA for alerts when major investors trade the stock.

Panbela Therapeutics is classified in the Technology sector. On total liabilities, it currently shows $23M. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Technology are usually more informative than comparing PBLA with unrelated industries.